Literature DB >> 9300250

Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas.

S Martinenghi1, G Comi, G Galardi, V Di Carlo, G Pozza, A Secchi.   

Abstract

Diabetic polyneuropathy is a common, disabling chronic complication of diabetes mellitus. Previous studies have suggested that combined pancreas-kidney transplantation can ameliorate nerve conduction. The relative contribution of the correction of hyperglycaemia and uraemia on nerve function is still a matter of debate. Nerve conduction velocity (NCV) was assessed before and after simultaneous pancreas and kidney transplantation, and before and after pancreas graft failure in five insulin-dependent diabetic (IDDM) patients affected by severe diabetic polyneuropathy. Sensory and motor NCV were recorded in five nerves and expressed as a cumulative index for each patient. Metabolic control was evaluated by fasting blood glucose and glycosylated haemoglobin levels. NCV index was below normal values before transplant: -3.8 +/- 0.7 (normal value: 0.89), improved 1 and 2 years after transplant: -3.1 +/- 1.3 and -2.6 +/- 0.9 (p = 0.0019), stabilised until pancreas failure and deteriorated to pre-transplant values 2 years after pancreas graft failure: -3.6 +/- 1.0 (p = 0.034). Fasting blood glucose levels worsened after pancreas graft failure. HbA1c levels, in the normal range during functioning pancreas graft (6.6 +/- 0.6%), deteriorated after its failure (8.0 +/- 0.6%, p = 0.04). Kidney function was preserved. These data support a positive effect of pancreas transplantation per se on NCV in IDDM subjects with diabetic polyneuropathy, thus demonstrating that metabolic control provided by a self-regulated source of insulin not only halts but also ameliorates nerve function, even if polyneuropathy is advanced.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300250     DOI: 10.1007/s001250050795

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

Review 1.  The effect of whole organ pancreas transplantation and PIT on diabetic complications.

Authors:  Timothy C Lee; Neal R Barshes; Erin E Agee; Christine A O'Mahoney; F Charles Brunicardi; John A Goss
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

2.  Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases.

Authors:  Daniele Velardo; Nilo Riva; Ubaldo Del Carro; Francesca Bianchi; Giancarlo Comi; Raffaella Fazio
Journal:  J Neurol       Date:  2017-03-23       Impact factor: 4.849

3.  Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy.

Authors:  E Bosi; M Conti; C Vermigli; G Cazzetta; E Peretti; M C Cordoni; G Galimberti; L Scionti
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

Review 4.  Pancreatic and islet transplantation.

Authors:  L Rosenberg
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 5.  Pancreas and kidney transplantation.

Authors:  Jennifer Larsen; James Lane; Lynn Mack-Shipman
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 6.  The role of kidney-pancreas transplantation in diabetic kidney disease.

Authors:  Alexander C Wiseman
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

Review 7.  [Pancreas and islet transplantation. The role in the treatment of diabetes mellitus].

Authors:  P Schenker; R Viebahn
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

Review 8.  The current state of pancreas transplantation.

Authors:  Rainer W G Gruessner; Angelika C Gruessner
Journal:  Nat Rev Endocrinol       Date:  2013-07-30       Impact factor: 43.330

Review 9.  Why is organ transplantation clinically important?

Authors:  Josep M Grinyó
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

10.  Kidney transplant in diabetic patients: modalities, indications and results.

Authors:  Erika B Rangel; João R de Sá; Cláudio S Melaragno; Adriano M Gonzalez; Marcelo M Linhares; Alcides Salzedas; José O Medina-Pestana
Journal:  Diabetol Metab Syndr       Date:  2009-08-26       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.